Twitter icon Email alerts icon Latest News RSS icon Magazine icon Stay connected:

View the article online at http://citywire.co.uk/wealth-manager/article/a740353

Overnight Markets: US stocks close little changed on China, Ukraine

by Himanshu Singh on Mar 13, 2014 at 03:28

Overnight Markets: US stocks close little changed on China, Ukraine

Wall Street closed little changed on Wednesday as investors watched developments in Ukraine but shrugged off concern over weakness in China's economy.

The Dow Jones industrial average declined 11 points or 0.07%, to 16,340, the S&P 500 gained one point to 1,868 and the Nasdaq Composite added 16 points or 0.37%, to 4,323.

The EU agreed a framework for its first sanctions on Russia since the Cold War, a stronger-than-expected response to the Ukraine crisis and a mark of solidarity with Washington in the effort to make Moscow pay for seizing Crimea.

London copper prices hit their lowest since July 2010 on concerns about credit problems in China, but later rebounded. Copper has fallen 7.7% over four sessions. Spot gold hit a six-month high on its safe-haven appeal.

In company news, Herbalife (HLF.N) fell 7.4% after the company said the US Federal Trade Commission had opened an inquiry into its operations.

Shares of Fannie Mae (FNMA.OB) and Freddie Mac (FMCC.OB) fell sharply, a day after leaders of the Senate Banking Committee announced an agreement on legislation to wind down the government-owned mortgage financiers. Fannie lost 12.2% and Freddie fell 16.8%.

In deal news, EPL Oil & Gas Inc (EPL.N) surged 28.8% after the company agreed to be acquired by larger rival Energy XXI Ltd (EXXI.O) for $2.3 billion including debt. Energy XXI shares lost 7.8%.

Express Inc (EXPR.N) fell 12% after the apparel retailer reported fourth-quarter earnings and forecast a profit for the current quarter that fell far short of analyst expectations.

Oxigene Inc (OXGN.O) surged 77.3% after the company said its experimental drug Zybrestat, combined with Roche's (ROG.VX) cancer drug Avastin, significantly slowed progression of recurrent ovarian cancer.

Geron Corp (GERN.O) lost 61.6% after the company said the US Food and Drug Administration ordered a halt to trials of a cancer drug over concerns about potential liver damage.

Sign in / register to view full article on one page

leave a comment

Please sign in here or register here to comment. It is free to register and only takes a minute or two.

News sponsored by:

Sponsored Video: Bringing it all back home


As the UK coalition government strives to rebalance the national economy, so called 'reshoring' looks set to play an increasingly important role in economic recovery.

Today's top headlines

Investing for income in a changing environment


With talk on interest rates on the horizon, our latest roundtable debate covers income investing against a changing backdrop

More about this:

Archive

On the road

Click here to find out more from the Audience Development team.

Sorry, this link is not
quite ready yet